Editor-in-Chief
Intralytix, Inc.
Baltimore, MD, US
Associate Editors
Stephen T. Abedon
Ohio State University
Mansfield, OH, US
University of Maryland
Baltimore, MD, US
University of California, Berkeley
Berleley, CA, US
Evergreen State College
Olympia, WA, US
Agricultural Research Service; United States Department of Agriculture
Beltsville, MD, US
Editorial Board
- Hans-W. Ackermann
-
Laval University
Quebec, QC, CA
- Heather E. Allison
-
University of Liverpool
Liverpool, England, UK
- Fumio Arisaka
-
Tokyo Institute of Technology
Yokohama, Kanagawa, JP
- Paul Barrow
-
University of Nottingham
Loughsborough, Leicestershire, UK
- E. Fidelma Boyd
-
University of Delaware
Newark, DE, US
- Martha Clokie
-
University of Leicester
Leicester, England, UK
- Terje Dokland
-
University of Alabama at Birmingham
Birmingham, AL USA - Vincent A. Fischetti
-
Rockefeller University
New York, NY, US
- Ipek Goktepe
-
Qatar University
Doha, Qatar - Lawrence Goodridge
-
Colorado State University
Fort Collins, CO, US
- Paul Gulig
-
University of Florida
Gainsville, FL, US
- Andrew Kropinski
-
PHA of Canada
Guelph, Canada
- Rob Lavigne
-
Katholieke Universiteit Leuven
Leuven, BE
- Petr Leiman
-
Ecole Polytechnique Fédérale de Lausanne (EPFL)
Lausanne, CH
- Martin Loessner
-
Swiss Federal Institute of Technology Zurich
Zurich, CH
- Konstantin A. Miroshnikov
-
Russian Academy of Sciences
Moscow, RU
- Glenn Morris
-
University of Florida
Gainesville, FL, US
- Daniel Nelson
-
University of Maryland
Rockville, MD, US
- Raul R. Raya
-
Centro de Referencia para Lactobacilos (CERELA-CONICET)
Tucuman, AR
- Catherine Reese
-
University of Nottingham
Leicestershire, England, UK
- David A. Schofield
-
Guild Associates, Inc.
Charleston, SC, US
- Philip Serwer
-
The University of Texas Health Science Center
San Antonio, TX, US
- Shanmuga Sozhamannan
-
Chemical Biological Medical Systems,
Ft. Detrick, MD USA
- Peter G. Stockley
-
University of Leeds
Leeds, England, UK
About the Editor-in-Chief
Dr. Alexander “Sandro” Sulakvelidze, Ph.D., is an Associate Professor of Molecular Genetics and Microbiology at the University of Florida College of Medicine, and Chief Scientist of Intralytix. Dr. Sulakvelidze is an internationally recognized expert in phage technology and infectious disease epidemiology. He has served/is serving as the Principal Investigator/Project Director of several grants and contracts from various agencies and foundations, including the National Institutes of Health (NIH), United States Department of Defense (DOD), United States Environmental Protection Agency (EPA), United States Department of Agriculture (USDA), National Food Processors Association (NFPA), Department of Health and Human Services Biotechnology Engagement Program (BTEP), and the Civilian Research and Development Foundation (CRDF). Dr. Sulakvelidze has published extensively on the subjects of molecular epidemiology and phage therapy, and he is the author of several issued and pending patents in the field of phage therapy. He also co-edited (with Dr. Elizabeth Kutter) a major book about bacteriophages, which was published by the CRC Press in 2005. Dr. Sulakvelidze’s phage research has been featured in several magazines and newspapers (including the Los Angeles Times, Newsweek, Science, Smithsonian and Wired), and in various radio programs and television documentaries (including National Public Radio’s Science Friday, BBC Radio and Voice of America radio programs, and BBC Horizon documentary about phage therapy). In addition to his service as Editor-in-Chief of Bacteriophage, Dr. Sulakvelidze serves as an ad hoc reviewer for (i) numerous journals, including Antimicrobial Agents and Chemotherapy, Applied and Environmental Microbiology, Drug Discovery Today, FEMS Immunology and Medical Microbiology, Clinical and Experimental Dermatology, Food Microbiology, Trends in Biotechnology, and Journal of Clinical Microbiology, and (ii) several funding agencies, including the CRDF, the International Science and Technology Center (ISTC), the U.S.-Israel Binational Science Foundation (BSF), and the NIH.
